Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-02 Sale | 2024-04-03 6:16 pm | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 28,000 | $26.25 | $734,919 | 985,132 (Direct) | View |
| 2024-03-08 Sale | 2024-03-12 5:29 pm | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 112,000 | $21.7 | $2,430,392 | 1,942,147 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 4:53 pm | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 84,000 | $20.13 | $1,691,306 | 1,125,132 (Direct) | View |
| 2024-01-22 Sale | 2024-01-23 3:13 pm | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 5,092 | $10.13 | $51,582 | 344,008 (Direct) | View |
| 2023-02-01 Sale | 2023-02-03 5:26 pm | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 50,000 | $24.35 | $1,217,727 | 3,396,718 (Direct) | View |
| 2022-11-09 Purchase | 2022-11-14 4:30 pm | OmniAb Inc. | OABI | Boyce Sarah Director | 36,000 | $2.8166 | $101,397 | 88,437 (Indirect Direct) | View |
| 2022-08-24 Sale | 2022-08-26 7:29 pm | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 49,900 | $22.88 | $1,141,614 | 2,308,885 (Direct) | View |
| 2022-08-15 Sale | 2022-08-17 9:40 pm | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 100 | $22.47 | $2,247 | 1,196,915 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 9:22 pm | Berkeley Lights Inc. | BLI | Boyce Sarah Director | 10,000 | $61.13 | $611,337 | 90,000 (Direct) | View |
| 2019-07-15 Sale | 2019-07-17 4:52 pm | AKCEA THERAPEUTICS INC. | AKCA | Boyce Sarah President | 1,819 | $23.52 | $42,783 | 19,888 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-11-01 Option Award(A) | 2024-04-23 5:37 pm | N/A N/A | OmniAb Inc. | OABI | Boyce Sarah Director | 39,628 | $0 | 48,381 (Direct) | View |
| 2024-04-02 Exercise | 2024-04-03 6:16 pm | N/A N/A | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 28,000 | $1.24 | 985,132 (Direct) | View |
| 2024-04-02 Exercise | 2024-04-03 6:16 pm | N/A 2029-12-17 | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 28,000 | $0 | 985,132 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-12 5:29 pm | N/A N/A | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 112,000 | $1.24 | 1,942,147 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-12 5:29 pm | N/A 2029-12-17 | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 112,000 | $0 | 1,942,147 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 4:53 pm | N/A N/A | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 84,000 | $1.24 | 1,125,132 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 4:53 pm | N/A 2029-12-17 | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 84,000 | $0 | 1,125,132 (Direct) | View |
| 2024-01-20 Option Award | 2024-01-23 3:13 pm | N/A 2034-01-19 | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 362,500 | $0 | 344,008 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-12 7:34 pm | N/A 2033-09-10 | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-27 5:44 pm | N/A N/A | OmniAb Inc. | OABI | Boyce Sarah Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-02-01 Exercise | 2023-02-03 5:26 pm | N/A N/A | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 50,000 | $1.24 | 3,396,718 (Direct) | View |
| 2023-02-01 Exercise | 2023-02-03 5:26 pm | N/A 2029-12-17 | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 50,000 | $0 | 3,396,718 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 2:10 pm | N/A 2033-01-30 | OmniAb Inc. | OABI | Boyce Sarah Director | 46,593 | $0 | 120,030 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 9:13 pm | N/A 2033-01-19 | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 450,000 | $0 | 453,352 (Direct) | View |
| 2022-11-01 Option Award | 2022-11-03 9:15 pm | N/A 2029-10-15 | OmniAb Inc. | OABI | Boyce Sarah Director | 122,452 | $0 | 122,452 (Direct) | View |
| 2022-11-01 Disposition | 2022-11-03 9:06 pm | N/A 2032-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Former Director Director | 5,344 | $0 | 2,892 (Direct) | View |
| 2022-08-24 Exercise | 2022-08-26 7:29 pm | N/A N/A | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 49,900 | $1.24 | 2,308,885 (Direct) | View |
| 2022-08-24 Exercise | 2022-08-26 7:29 pm | N/A 2029-12-17 | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 49,900 | $0 | 2,308,885 (Direct) | View |
| 2022-08-15 Exercise | 2022-08-17 9:40 pm | N/A N/A | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 100 | $1.24 | 1,196,915 (Direct) | View |
| 2022-08-15 Exercise | 2022-08-17 9:40 pm | N/A 2029-12-17 | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 100 | $0 | 1,196,915 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 6:47 pm | N/A 2032-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Director | 5,344 | $0 | 8,236 (Direct) | View |
| 2022-01-21 Option Award | 2022-03-15 9:15 pm | N/A 2032-01-20 | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 425,000 | $0 | 425,000 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-07 9:25 pm | N/A 2031-06-04 | LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Director | 3,899 | $0 | 6,161 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 9:46 pm | N/A 2031-05-13 | Berkeley Lights Inc. | BLI | Boyce Sarah Director | 6,300 | $0 | 6,300 (Direct) | View |
| 2021-03-01 Exercise | 2021-03-03 9:22 pm | N/A N/A | Berkeley Lights Inc. | BLI | Boyce Sarah Director | 10,000 | $8.9 | 90,000 (Direct) | View |
| 2021-03-01 Exercise | 2021-03-03 9:22 pm | N/A 2029-09-11 | Berkeley Lights Inc. | BLI | Boyce Sarah Director | 10,000 | $0 | 90,000 (Direct) | View |
| 2021-02-02 Option Award | 2021-02-04 5:11 pm | N/A 2031-02-01 | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 300,000 | $0 | 300,000 (Direct) | View |
Ownership | 2020-07-16 5:10 pm | N/A 2029-09-11 | Berkeley Lights Inc. | BLI | Boyce Sarah Director | 0 | $0 | 100,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:35 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Director | 3,299 | $0 | 4,730 (Direct) | View |
Ownership | 2020-06-11 8:16 pm | N/A 2019-12-17 | Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO | 0 | $0 | 1,197,015 (Direct) | View |
| 2019-10-15 Option Award | 2019-10-16 6:01 pm | 2020-10-15 2029-10-15 | LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Director | 6,714 | $0 | 6,714 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-03 4:31 pm | N/A N/A | AKCEA THERAPEUTICS INC. | AKCA | Boyce Sarah President | 813 | $20.04 | 21,707 (Direct) | View |